No credible evidence to support cardiac risk of testosterone therapy

No credible evidence to support cardiac risk of testosterone therapy
Credit: 2014 Mary Ann Liebert, Inc., publishers

Recent articles in the scientific literature and mass media that question the use of testosterone (T) therapy to treat T deficiency, or "low T," and assert the cardiovascular risks of T therapy, are flawed, according to a provocative Guest Editorial in Journal of Men's Health.

In "Testosterone Therapy and Cardiovascular Risk: A Cautionary Tale" Martin Miner, MD, The Warren Alpert School of Medicine, Brown University (Providence, RI), Joel Heidelbaugh, MD, University of Michigan Medical School (Ann Arbor), and Abraham Morgentaler, MD, Harvard Medical School (Boston, MA), state, "We object to comments that question the reality of T deficiency, regardless of whether it is called hypogonadism or, as in advertisements, 'low T.'"

More data from larger, longer term studies are needed to assess potential effects of on in men. Based on the current evidence, the authors state, "we can find no foundation for suggesting new restrictions on T therapy in men with cardiac disease."


Explore further

Large clinical trials to evaluate risks of testosterone treatment urgently needed

More information: The article is available free on the Journal of Men's Health website at http://www.liebertpub.com/jmh.
Citation: No credible evidence to support cardiac risk of testosterone therapy (2014, May 5) retrieved 3 August 2021 from https://medicalxpress.com/news/2014-05-credible-evidence-cardiac-testosterone-therapy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments